Fixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: analysis by prostaglandin analogue

References

• RahmanMQAbeysingheSSKellySPersistence of glaucoma medical therapy in the Glasgow glaucoma databaseBr J Ophthalmol201195796697021258080
   PubMed Web of Science ®Google Scholar
• WernerEBDranceSMProgression of glaucomatous field defects despite successful filtrationCan J Ophthalmol1977124275280922569
   PubMed Web of Science ®Google Scholar
• KassMAHeuerDKHigginbothamEJThe ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary-open angle glaucomaArch Ophthalmol2002120670171312049574
   PubMed Web of Science ®Google Scholar
• DunkerSSchmuckerAMaierHLatanoprost/Timolol Fixed Combination Study GroupTolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timololAdv Ther200724237638617565929
   PubMed Web of Science ®Google Scholar
• CostaVPMoreiraHPaoleraMDde Moraes SilvaMREfficacy and safety of travoprost 0.004%/timolol 0.5% fixed combination as transition therapy in patients previously on prostaglandin analog monotherapyClin Ophthalmol2012669970622654495
   PubMedGoogle Scholar
• PfeifferNScherzerMLMaierHSafety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from preceding mono- or adjunctive therapyClin Ophthalmol2010445946620505839
   PubMedGoogle Scholar
• ArendKORaberTObservational study results in glaucoma patients undergoing a regimen replacement to fixed combination travoprost 0.004%/timolol 0.5% in GermanyJ Ocul Pharmacol Ther200824441442018665813
   PubMed Web of Science ®Google Scholar
• ParanhosAMendonçaMSilvaMJHyperemia reduction after administration of a fixed combination of bimatoprost and timolol maleate to patients on prostaglandin or prostamide monotherapyJ Ocul Pharmacol Ther201026661161521029020
   PubMed Web of Science ®Google Scholar
• DjafariFLeskMRHarasymowyczPJDesjardinsDLachaineJDeterminants of adherence to glaucoma medical therapy in a long-term patient populationJ Glaucoma200918323824319295380
   PubMed Web of Science ®Google Scholar
• SleathBRobinALCovertDByrdJETudorGSvarstadBPatient-reported behavior and problems in using glaucoma medicationsOphthalmology2006113343143616458967
   PubMed Web of Science ®Google Scholar
• ChraiSSMakoidMCEriksenSPRobinsonJRDrop size and initial dosing frequency problems of topically applied ophthalmic drugsJ Pharm Sci19746333333384820359
   PubMed Web of Science ®Google Scholar
• HigginbothamEJConsiderations in glaucoma therapy: fixed combinations versus their component medicationsClin Ophthalmol201041920169043
   PubMedGoogle Scholar
• NakanoTMizoueSFuseNIwaseAMatsumotoSYoshikawaKFixed combination of travoprost and timolol maleate reduces intraocular pressure in Japanese patients with primary open-angle glaucoma or ocular hypertension: a prospective multicenter open-label studyAdv Ther201532982383726424331
   PubMed Web of Science ®Google Scholar
• TianjingLiLindsleyKRouseBComparative effectiveness of first-line medications for primary open-angle glaucoma: a systematic review and network meta-analysisOphthalmology2016123112914026526633
   PubMed Web of Science ®Google Scholar
• LinLiangZhaoYJChewPTComparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertensionAnn Pharmacother201448121585159325184309
   PubMed Web of Science ®Google Scholar
• KonstasAGQuarantaLKatsanosATwenty-four hour efficacy with preservative free tafluprost compared with latanoprost in patients with primary open angle glaucoma or ocular hypertensionBr J Ophthalmol201397121510151523681371
   PubMed Web of Science ®Google Scholar
• FukudaMSasakiHThe transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyesJ Ocul Pharmacol Ther2015311576025303115
   PubMed Web of Science ®Google Scholar
• QuarantaLRivaIKatsanosAFlorianiICentofantiMKonstasAGSafety and efficacy of travoprost solution for the treatment of elevated intraocular pressureClin Ophthalmol2015963364325914522
   PubMed Web of Science ®Google Scholar
• QuarantaLBiagioliERivaIProstaglandin analogs and timolol-fixed versus unfixed combinations or monotherapy for open-angle glaucoma: a systematic review and meta-analysisJ Ocul Pharmacol Ther201329438238923231442
   PubMed Web of Science ®Google Scholar
• IwaseASuzukiYAraieMThe prevalence of primary open-angle glaucoma in Japanese. The Tajimi StudyOphthalmology200611381354136216877074
   PubMed Web of Science ®Google Scholar
• YamamotoTIwaseAAraieMThe Tajimi Study Report 2 prevalence of primary angle closure and secondary glaucoma in a Japanese populationOphthalmology2005112101661166916111758
   PubMed Web of Science ®Google Scholar
• Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Collaborative Normal-Tension Glaucoma Study GroupAm J Ophthalmol199812644985059780094
   PubMed Web of Science ®Google Scholar
• DreerLEOwsleyCCampbellLGaoLWoodAGirkinCAFeasibility, patient acceptability, and preliminary efficacy of a culturally informed, health promotion program to improve glaucoma medication adherence among African Americans: “Glaucoma management optimism for African Americans living with Glaucoma” (GOAL)Curr Eye Res2016411505825625187
   PubMed Web of Science ®Google Scholar
• HollóGTopouzisFFechtnerRDFixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practiceExpert Opin Pharmacother201415121737174724998246
   PubMed Web of Science ®Google Scholar